HUMAN AMYLOID IMAGING CONFERENCE

The 18th edition of the HAI will be held in San Juan, Puerto Rico on January 12-14, 2026.

HAI 2025 POSTER SESSIONS

Click the “+” to open each module; tables can be sorted by clicking on each item of the header row (board number, poster title, authors and presenter, respectively). Additionally, each table is searchable (use the search field located at the top right of each module).

Please note that we reserve the right to re-arrange the poster allocation.

POSTER SESSIONS: 1A - Wednesday, January 15 - 10:40 am - 12:35 pm; 1B - Wednesday, January 15, 4:30 - 5:25 pm

Show entries

Search:

Board #	Title	Authors	Presenter
01	Decline in everyday functioning over time relates to amyloid and tau in cognitively unimpaired older adults	Dubbelman \| Liu \| Donohue \| Langford \| Raman \| Rentz \| Amariglio \| Sperling \| Aisen \| Marshall	Dubbelman, Mark
02	From the clinical utility of a-synuclein PET imaging in Multiple System Atrophy to the possible diagnosis of Parkinson’s disease	Vokali \| Molette \| Rodriguez \| Changizi2 \| Kuzkina \| Ravache \| Dimitrakopoulos \| Delgado \| Kocher \| Pittet \| Vallet \| Hliva \| Pfeifer \| Kosco-Vilbois \| Derouazi \| Khurana \| Capotosti	Capotosti, Francesca
03	Unraveling the impact of amyloid-β and tau pathology on brain structure and cognitive function during preclinical and prodromal Alzheimer’s disease	Qiu \| Liu \| Gallego-Rudolf \| Edde \| Caron \| Zhang \| Soucy \| Spreng \| Descoteaux \| Villeneuve	Qiu, Ting
04	Astrogliosis, a potential non-Aβ pathway to tau	Villemagne \| Cohen \| Lopresti \| Saeed \| Tudorascu \| Gogola \| Matan \| Reese \| Snitz \| Ikonomovic \| Reis \| Launer \| Lopez	Villemagne, Victor L
05	APOE ε4 carriers exhibit attenuated habituation in pupil size and practice effects on a repeated auditory oddball task	Grube \| Rodríguez Alonso \| Engels-Domínguez \| Jacobs \| Riphagen	Grube, Jill
06	Baseline tau burden and performance on a digital clock drawing test uniquely contributes to predicting future tau accumulation in preclinical AD	Fu \| Robinson \| Farrell \| Jutten \| Thibault \| Rodriguez Alonso \| Thompson \| Lois \| Tiss \| Gong \| Chen \| Penney \| Davis \| Sperling \| Johnson \| Rentz \| Price	Fu, Jessie Fang-Lu
07	Molecular correlates of apraxia in Alzheimer's disease: A PET imaging study	Bischof \| Jaeger \| Giehl \| jessen \| Onur \| O'Bryant \| Kara \| Weiss \| Drzezga	Bischof, Gerard
08	Understanding the impact of race on white matter hyperintensities in Alzheimer’s disease: Findings from the ADNI Study	Ekuta \| Ahn \| Tripodis \| Hamilton	Ekuta, Victor
09	Characterization of a limbic-predominant amnestic neurodegenerative syndrome	Corriveau-Lecavalier \| Waniger \| Stricker \| Machulda \| Fields \| Botha \| Graff-Radford \| Ramanan \| McCarter \| Nguyen \| Reichard \| Boeve \| Knopman \| Lowe \| Dickson \| Murray \| Graff-Radford \| Petersen \| Jack \| Jones	Corriveau-Lecavalier, Nick
10	Positron emission tomography analysis with the dynamicpet Python package	Bilgel \| Amer \| Bae \| Bouhrara \| Gong \| Guo \| Uriarte-Lopez \| Singh \| Matheson \| Nørgaard	Bilgel, Murat
11	Targeted plasma eQTL and pQTL to identify potential novel biomarker for Alzheimer's Disease in African Americans	Colón-Badillo \| Reddy \| Jin \| Lincoln \| Ho \| Crook \| Wang \| Malphrus \| Nguyen \| Marrero-Polanco \| Tamvaka \| Lucas \| Graff-Radford \| Ertekin-Taner \| Carrasquillo	Colón-Badillo, Vanessa
12	Pathological and clinical trajectories of preclinical Alzheimer’s disease patients with divergent cortical tau patterns	Young \| Carlson \| Cody \| Winer \| Schultz \| Mormino	Mormino, Elizabeth
13	Evaluation of a label-free X-ray based method for estimating amyloid load in the human brain	Geremia \| Amer \| Dahal \| Badano	Geremia, Danielle
14	Proteomic analyses of A-T-N reveal plasma mediators of neurodegeneration and dementia risk	Duggan \| Bilgel \| Chen \| Moghekar \| Davatzikos \| Coresh \| Resnick \| Walker	Duggan, Michael
15	The spatial spread of tauopathy precedes the increase in tau-PET load in Alzheimer’s disease	Cassa Macedo \| Therriault \| Rahmouni \| Tissot \| Aumont \| Wang \| Servaes \| Trudel \| Hall \| Hosseini \| Fernandez-Arias \| Bezgin \| Chan \| Zheng \| Ferrari-Souza \| Ferreira \| Bellaver \| Lussier \| Pascoal \| Rosa-Neto	Cassa Macedo, Arthur
16	Distinct patterns of Iron distribution in the entorhinal cortex-hippocampus system for characterization of mild cognitive impairment	Kagerer \| Vionnet \| van Bergen \| Meyer \| Gietl \| Prüssmann \| Hock \| Unschuld	Unschuld, Paul
17	Pathological asymmetry in early onset AD reflects heterogenous disease trajectories	Ziontz \| Maiti \| Zhang \| Chiotis \| Blazhenets \| Rocha \| Shankar \| Amuiri \| Schonhaut \| Hammers \| Eloyan \| Koeppe \| Carrillo \| Dickerson \| Apostolova \| Rabinovici \| La Joie	Ziontz, Jacob
18	Characterizing amyloid-positive with low Tau (A+T-) profiles and their association with cognitive trajectories in the Longitudinal Early-Onset Alzheimer’s Disease Study (LEADS): A multi-method approach	Abu Raya \| Soleimani-Meigooni \| Schonhaut \| Blazhenets \| Chiotis \| Lagarde \| Vrillon \| Maiti \| Windon \| Zeltzer \| Zhang \| Yballa \| Shankar \| Amuiri \| Rocha \| Hammers \| Eloyan \| Carrillo \| Koeppe \| Dickerson \| Apostolova \| Rabinovici \| La Joie	Abu Raya, Maison
19	The association between amyloid and physical activity in a racially diverse cohort of older adults	Dong \| Wu \| Minhas \| Laymon \| Villemagne \| Lopez \| Snitz \| Gogniat \| Glynn \| Tudorascu \| Cohen	Dong, Yiwen

Showing 1 to 19 of 58 entries

Previous Next

POSTER SESSIONS: 2A - Thursday, January 16 - 10:05 - 11:00 am; 2B - Thursday, January 16, 3:55 - 4:50 pm

Show entries

Search:

Board #	Title	Authors	Presenter
59	Interpretable prediction of amyloid PET positivity using non-negative matrix factorization	Zhang \| Barnard \| Gogineni \| Corriveau-Lecavalier \| Botha \| Burkett \| Johnson \| Lowe \| McCarter \| Ramanan \| Graff-Radford \| Knopman \| Petersen \| Jones	Jones, David
60	Data-driven biomarker discovery nominates novel diagnostic plasma biomarkers and provides insights into Alzheimer’s disease pathophysiology in an African American cohort	Kuchenbecker \| Thompson \| Hurst \| Opdenbosch \| Heckman \| Reddy \| Nguyen \| Casellas \| Sotelo \| Redy \| Lucas \| Day \| Willis \| Graff-Radford \| Ertekin-Taner \| Kalari \| Carrasquillo	Kuchenbecker, Lindsey
62	Longitudinal multicenter head-to-head harmonization of tau PET tracers: an overview of the HEAD study cohort	Lussier \| Povala \| Bauer-Negrini \| Silva do Amaral \| Lukasewicz Ferreira \| Bellaver \| Masdeu \| Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Lussier, Firoza
63	Higher time varying brain functional connectivity is associated with slower tau accumulation at the preclinical stage of Alzheimer’s disease	Javanray \| St-Onge \| Bellec \| Misic \| Soucy \| Villenueve	Javanray, Mohammadali
64	Graph convolutional networks to predict cognitive decline at the individual level in Alzheimer’s disease	Kang \| Heaton \| Nyman \| Biparva \| McSweeney \| Ottoy \| Masellis \| Shirzadi \| Johnson \| Sperling \| Schultz \| Jasmeer \| Swardfager \| Lipsman \| Black \| Rabin \| Goubran	Kang, Min Su
65	Low tau in Aβ-positive cognitively impaired individuals: Alzheimer’s disease or something more?	Ioannou \| Abdullaieva \| J. Perrin \| Bluma \| Poulakis \| Leuzy \| Religa \| Rodriguez-Vieitez \| Chiotis	Ioannou, Konstantinos
66	A plasma clock for Alzheimer disease based on %p-tau217	Petersen \| Milà-Alomà \| Tosun \| Li \| Shaw \| Dage \| Zetterberg \| Saef \| Holtzman \| Morris \| Xiong \| Bateman \| Bannon \| Potter \| Schindler	Petersen, Kellen K.
67	Network-based amyloid-β pathology predicts subsequent cognitive decline in cognitively normal older adults	He \| Razlighi \| Gazes \| Habeck \| Stern	He, Hengda
68	Associations between APOE-TOMM40 ‘523 haplotype variants and limbic system white matter microstructure in Black and White individuals	Mooney \| Archer \| Sathe \| Hohman \| Kadiri \| Lamar \| Arfanakis \| Yu \| Barnes \| Deters	Mooney, Katelyn
69	Multi element MRI template method for analysis of Down syndrome PET	Laymon \| Minhas \| Heffley \| Gilmore \| Kondaveeti \| Gogola \| Royse \| Joshi \| Lopresti \| Luo \| Davuluri \| Matan \| Tudorascu \| Christian \| Zaman \| Beau \| Cohen \| Handen	Laymon, Charles
70	Whole-blood gene expression associations with Aβ-PET accumulation and cognitive decline	Klinger \| Janve \| Seto \| Brown \| Birkenbihl \| Coughlan \| Townsend \| Zyski \| Wang \| Amariglio \| Papp \| Rentz \| Yang \| Chhatwal \| Clifton \| Donohue \| Raman \| Rissman \| Aisen \| Johnson \| Sperling \| Dumitrescu \| Hohman \| Buckley	Klinger, Hannah
71	Longitudinal change in five dominant dimensions of brain aging in relation to brain amyloid status and Alzheimer’s-related plasma biomarkers	Bilgel \| Shah \| Cooper \| An \| Walker \| Moghekar \| Yang \| Erus \| Davatzikos \| Resnick	Bilgel, Murat
72	Enrichment of patients with concomitant LATE on the Alzheimer’s disease continuum using hippocampal volume	Mundada \| Lyu \| Sadeghpour \| Brown \| McCrew \| Xie \| Yushkevich \| Das \| Wolk	Mundada, Nidhi
73	AT(N) staging of Alzheimer’s disease: Comparison of visual interpretation and automated quantification pipelines	Lopresti \| Cohen \| DelBene \| Reese \| Matan \| Gogola \| Chiang \| Snitz \| Royse \| Lopez \| Villemagne	Lopresti, Brian
74	MK-6240 off-target binding patterns in relation to microglia density, measured through TSPO PET	Heuer \| Johnson \| Smith \| Guzman \| Houlihan \| Okafor \| Sanchez \| Talmasov \| Dass \| Chikwem \| Provenzano \| Kreisl \| Noble \| Small \| Lao	Heuer, Lauren
75	Association between medication use and [18F]MK6240 and [18F]Flortaucipir uptake across the Alzheimer's disease spectrum	Mroué \| Lukasewicz Ferreira \| Povala \| Bellaver \| Bauer-Negrini \| Lussier \| Amaral \| Scop Medeiros \| Ruppert \| Silva da Rocha \| Scarpatto Rodrigues \| Silva Oliveira \| Soares Katz \| Teixeira Leffa \| Saha \| Felix \| Masdeu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| Gordon \| Rosa-Neto \| Baker \| Pascoal	Mroué, Rayan
76	Lower LC-EC tract integrity is associated with entorhinal tau in autosomal-dominant Alzheimer’s disease	Koops \| Giudicessi \| Bonillas-Felix \| Medrano \| Martinez \| Gonzalez \| Alvarez \| Aguillon \| Quiroz \| Jacobs	Koops, Elouise
77	APOE4 associated with higher off-target meninges signal with [F-18]MK6240 PET	McVea \| DiFilippo \| McLachlan \| Bettcher \| Tudorascu \| Johnson \| Zammit \| Betthauser \| Christian	McVea, Andrew
78	An accurate and automated technique for removing spill-over contamination and off-target retention from a cerebellar reference region for tau PET	Minhas \| DelBene \| Gogola \| Reese \| Luo \| Laymon \| Lopresti \| Dore \| Pascoal \| Baker \| Tudorascu \| Villemagne	Minhas, Davneet

Showing 1 to 19 of 55 entries

Previous Next

POSTER SESSIONS: 3A - Friday, January 17, 10:45 - 11:40 am; 3B - Friday, January 17, 2:55 - 3:50 pm

Show entries

Search:

Board #	Title	Authors	Presenter
117	Concordance between visual and quantitative amyloid PET and CSF biomarkers in the ADNI-DOD cohort	Vrillon \| Blazhenets \| Lagarde \| Chiotis \| Abu Raya \| Soleimani-Meigooni \| Rabinovici \| Weiner \| Silbert \| Hantke \| Schwartz \| Livny Ezer \| Lesman Segev \| Yaffe \| Shaw \| Landau \| La Joie \| Gardner	Vrillon, Agathe
118	Calibration of multi-site raters for prospective visual read of amyloid PET scans acquired across the ADRC Consortium for Clarity in ADRD Research Through Imaging (CLARiTI)	Soleimani-Meigooni \| Blazhenets \| La Joie \| Lin \| Soppe \| Johnson \| Koran \| McConathy \| Nasrallah \| Tanner \| Villemagne \| Windon \| Zeineh \| Mormino \| Johnson \| Rabinovici	Soleimani-Meigooni, David
119	Evaluating the effect of APOE genotype in real-world clinical settings: results from the IDEAS-ANGI study	Pezzoli \| Jonson \| Blazhenets \| Schonhaut \| Perez \| Oddi \| Castruita \| Casaletto \| Hanna \| March \| Gatsonis \| Carrillo \| Foroud \| La Joie \| Yokoyama \| Rabinovici	Pezzoli, Stefania
120	Brain connectivity drives tau distribution while regional vulnerability drives tau load in Alzheimer’s disease	Xiao \| Bazinet \| Strandberg \| Hansen \| Shafiei \| Spotorno \| Behjat \| Stomrud \| Smith \| Palmqvist \| Mattsson-Carlgren \| Dagher \| Misic \| Hansson \| Vogel	Xiao, Yu
121	Synergistic effects of peripheral inflammation and neuroinflammation on amyloid, vascular, and neurodegeneration markers across the Alzheimer’s disease spectrum	Ramirez Tirado \| Cohen \| Shaaban \| Matan \| Lopresti \| Ikonomovic \| Karikari \| Villemagne \| Lopez	Ramirez Tirado, Laura
122	Impact of amyloid removal on cerebral volume changes with Gantenerumab	Tonietto \| Silvestri \| Belder \| Barkhof \| Fox \| Smith \| Klein	Tonietto, Matteo
123	Astrocyte reactivity explains tau-related effects on hippocampal dysfunction and longitudinal atrophy in preclinical Alzheimer’s disease	Schweitzer \| Iordanova \| Chen \| Jin \| Thurston \| Lopresti \| Snitz \| Tudorascu \| Cohen \| Kamboh \| Halligan-Eddy \| Karikari \| Villemagne \| Aizenstein \| Wu	Schweitzer, Noah
124	Plasma phosphorylated tau 217 and longitudinal trajectories of Aβ, tau, and cognition in cognitively unimpaired older adults	Yang \| Anzai \| Yau \| Román Viera \| Maa \| Kirn \| Properzi \| Schultz \| Farrell \| Jacobs \| Buckley \| Papp \| Marshall \| Amariglio \| Rentz \| Braunstein \| Johnson \| Sperling \| Chhatwal	Yang, Hyun-Sik
125	Detection of TDP-43 from plasma-derived astrocyte extracellular vesicles for identification of LATE	Rissman	Rissman, Robert
126	Short sleep duration is associated with higher subsequent plasma p-tau217 in aging	Winer \| Cody \| Young \| Mormino	Winer, Joseph
127	Impacts of testing language and rates of amyloid positivity among underrepresented groups in the A4 Study	Sai \| D. Grill \| C. Mormino \| B Young	Sai, Isha
128	Lower locus coeruleus metabolism is associated with greater year-to-year intraindividual cognitive variability in older individuals with elevated levels of Alzheimer’s disease pathology	Wiklund \| Van Egroo \| Koops \| Hanseeuw \| Papp \| Rentz \| Sperling \| Johnson \| Jacobs	Wiklund, Emma
129	Long-term cognitive and biomarker trajectories of cognitively unimpaired individuals with elevated plasma ptau-217	Silva-Rodríguez \| Zhang \| Valeriano-Lorenzo \| López-González \| Wagner-Reguero \| del Ser \| Grothe \| Sánchez-Juan	Silva-Rodríguez, Jesús
130	A large public release of PIB PET and MRI from the Mayo Clinic Study of Aging	Schwarz \| Kremers \| Prakaashana \| Przybelski \| Christenson \| Williams \| Gunter \| Senjem \| Arani \| Reid \| Machulda \| Fields \| Lowe \| Kantarci \| Graff-Radford \| Vemuri \| Petersen \| Knopman \| Jack	Schwarz, Christopher
131	Harmonizing visual readings of Flortaucipir and MK-6240 using head-to-head data	Ruppert \| Medeiros \| Rocha \| Soares \| Amaral \| Povala \| Bauer-Negrini \| L. Ferreira \| Lussier \| Oliveira Jr. \| Scarpatto Rodrigues \| Mroue \| Zalzale \| Leffa \| Saha \| Bellaver \| L. Tudorascu \| Soleimani-Meigooni \| Fortea \| Lowe \| Oh \| Pascual \| A. Gordon \| Rosa-Neto \| Baker \| A. Pascoal	Ruppert, Emma
132	Twin-mapping techniques in clinical trials: a proof-of-concept application to the Internet-Based Conversational Engagement Clinical Trial (I-CONECT)	Wu \| Chen \| Arnold \| Dodge	Wu, Chao-Yi
133	Effects of amyloid and tau status on multiplex plasma CNS and inflammatory proteins in a normal aging cohort	Trelle \| Cody \| Nguyen \| Winer \| Weiss \| Romero \| Sai \| Wilson \| Wagner \| Maecker \| Mormino	Cody, Karly
134	Tau imaging thresholds within NIA-AA multilevel tau staging as predictors of tau accumulation and cognitive decline in non-demented individuals	Gogola \| Cohen \| Snitz \| Minhas \| Tudorascu \| Ikonomovic \| Shaaban \| Dore \| Matan \| DelBene \| Bourgeat \| Leuzy \| Aizenstein \| Lopez \| Lopresti \| Villemagne	Gogola, Alexandra
135	Multi-morbidity and Alzheimer’s disease pathology across the lifespan in adults with Down syndrome	Smith \| Edwards \| Flores Aguilar \| Alshikho \| Tudorascu \| Rosas \| Yassa \| Hartley \| Handen \| Christian \| Gutierrez \| Wilcock \| Head \| Brickman \| Lao	Smith, Anna

Showing 1 to 19 of 58 entries

Previous Next

HUMAN AMYLOID IMAGING CONFERENCE

HAI 2025 POSTER SESSIONS

POSTER SESSIONS: 1A - Wednesday, January 15 - 10:40 am - 12:35 pm; 1B - Wednesday, January 15, 4:30 - 5:25 pm

POSTER SESSIONS: 2A - Thursday, January 16 - 10:05 - 11:00 am; 2B - Thursday, January 16, 3:55 - 4:50 pm

POSTER SESSIONS: 3A - Friday, January 17, 10:45 - 11:40 am; 3B - Friday, January 17, 2:55 - 3:50 pm

HAI Past Poster Sessions